Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IVERMECTIN Cause Drug effective for unapproved indication? 57 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Drug effective for unapproved indication have been filed in association with IVERMECTIN (Ivermectin). This represents 1.9% of all adverse event reports for IVERMECTIN.

57
Reports of Drug effective for unapproved indication with IVERMECTIN
1.9%
of all IVERMECTIN reports
0
Deaths
6
Hospitalizations

How Dangerous Is Drug effective for unapproved indication From IVERMECTIN?

Of the 57 reports, 6 (10.5%) required hospitalization.

Is Drug effective for unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IVERMECTIN. However, 57 reports have been filed with the FAERS database.

What Other Side Effects Does IVERMECTIN Cause?

Drug ineffective (538) Product use in unapproved indication (366) Off label use (288) Pruritus (217) Erythema (204) Rosacea (131) Skin burning sensation (113) Headache (112) Rash (105) Condition aggravated (89)

What Other Drugs Cause Drug effective for unapproved indication?

DICLOFENAC (6,550) ACETAMINOPHEN\ASPIRIN\CAFFEINE (3,300) ACETAMINOPHEN\IBUPROFEN (1,620) IBUPROFEN (1,530) RITUXIMAB (1,233) DIPHENHYDRAMINE\IBUPROFEN (864) TOFACITINIB (669) PREDNISONE (657) NAPROXEN (499) BEVACIZUMAB (461)

Which IVERMECTIN Alternatives Have Lower Drug effective for unapproved indication Risk?

IVERMECTIN vs IVOSIDENIB IVERMECTIN vs IXABEPILONE IVERMECTIN vs IXAZOMIB IVERMECTIN vs IXEKIZUMAB IVERMECTIN vs JAKAFI

Related Pages

IVERMECTIN Full Profile All Drug effective for unapproved indication Reports All Drugs Causing Drug effective for unapproved indication IVERMECTIN Demographics